Related Experiment Video
Updated: Aug 15, 2025
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
Published on: January 26, 2024
Computational insights for predicting the binding and selectivity of peptidomimetic plasmepsin IV inhibitors against
Lucas Sousa Martins1, Hendrik Gerhardus Kruger2, Tricia Naicker2
1Laboratório de Planejamento e Desenvolvimento de Fármacos, Instituto de Ciências Exatas e Naturais, Universidade Federal do Pará Belém Pará 66075-110 Brazil lucasmartins.quim@gmail.com lameira@ufpa.br nahum@ufpa.br rogerio@ufpa.br.
Abstract:
Plasmepsins (Plms) are aspartic proteases involved in the degradation of human hemoglobin by P. falciparum and are essential for the survival and growth of the parasite. Therefore, Plm enzymes are reported as an important antimalarial drug target. Herein, we have applied molecular docking, molecular dynamics (MD) simulations, and binding free energy with the Linear Interaction Energy (LIE) approach to investigate the binding of peptidomimetic PlmIV inhibitors with a particular focus on understanding their selectivity against the human Asp protease cathepsin D (CatD). The residual decomposition analysis results suggest that amino acid differences in the subsite S3 of PlmIV and CatD are responsible for the higher selectivity of the 5a inhibitor. These findings yield excellent agreement with experimental binding data and provide new details regarding van der Waals and electrostatic interactions of subsite residues as well as structural properties of the PlmIV and CatD systems.
Insights
Plasmepsins (Plms) are key malaria parasite targets. This study reveals specific amino acid differences in PlmIV and CatD explain inhibitor selectivity, aiding antimalarial drug design.
Area of Science:
- Biochemistry
- Parasitology
- Medicinal Chemistry
Background:
- Plasmepsins (Plms) are essential aspartic proteases from *P. falciparum*, crucial for parasite survival via hemoglobin degradation.
- Plm enzymes represent a significant target for antimalarial drug development.
Purpose of the Study:
- To investigate the binding of peptidomimetic inhibitors to PlmIV.
- To understand the selectivity of these inhibitors against human aspartic protease cathepsin D (CatD).
Main Methods:
- Molecular docking simulations
- Molecular dynamics (MD) simulations
- Linear Interaction Energy (LIE) approach for binding free energy calculations
- Residual decomposition analysis
Main Results:
- Identified specific amino acid differences in the S3 subsite of PlmIV and CatD as key to inhibitor selectivity.
- The 5a inhibitor demonstrated higher selectivity due to these S3 subsite variations.
- Detailed insights into van der Waals and electrostatic interactions governing inhibitor binding.
Conclusions:
- The study provides a molecular basis for the selectivity of PlmIV inhibitors against CatD.
- Findings align with experimental data, validating the computational approach.
- Offers valuable information for designing more effective and selective antimalarial drugs.
Related Concept Videos
02:04Protein-protein Interfaces
01:49Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...